首页> 外文OA文献 >Achieving the composite end‐point of glycated hemoglobin <7.0 without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis

【2h】

Achieving the composite end‐point of glycated hemoglobin <7.0 without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis

机译：在中国患有2型糖尿病患者的患者中，糖化血红蛋白的复合血红蛋白<7.0％的复合末端点或低血糖患者患有2型糖尿病患者的一次性杜拉蛋白质：HOC分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Xinhua Xiao; Changjiang Wang; Xiaoyang Lai; Bin Zhang; Liqun Gu; Jianing Hou; Zhiguang Zhou;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Achieving the composite end‐point of glycated hemoglobin 7.0% without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type?2 diabetes: A post‐hoc analysis [J] . Xinhua Xiao, Changjiang Wang, Xiaoyang Lai, Journal of diabetes investigation. . 2020,第3期

机译：在中国患者2型糖尿病患者中达到糖化血红蛋白<7.0％的复合血红蛋白<7.0％的血红蛋白<7.0％的糖尿病或低血糖蛋白质：HOC分析后分析
2. Weight loss in patients with type 2 diabetes receiving once‐weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post‐hoc post‐hoc analysis of the AWARD‐4 study across baseline body mass index subgroups [J] . Fuechtenbusch Martin, Aberle Jens, Heitmann Elke, Diabetes, obesity & metabolism . 2019,第6期

机译：2型糖尿病患者减肥患者接受每周达拉蛋白质的杜拉替纳蛋白酶胰岛素LISPRO或胰岛素狼甘蓝加胰岛素LISPRO：基线体重指数亚组奖励-4研究后HOC后HOC分析
3. Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type?2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials [J] . Lixin Guo, Bin Zhang, Jianing Hou, Diabetes therapy . 2020,第8期

机译：评估胃肠道不良事件的特征，用型糖尿病患者持续每周杜拉蛋白质治疗：两次随机试验的后HOC汇总分析
4. Analysis of diabetic comorbidities and their interrelationships in 5227 Chinese patients with type 2 diabetes [C] . Yifei Wang, Ying Xing, Min Pi, IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：糖尿病患者2型糖尿病患者糖尿病患者的相互关系分析及其相互关系
5. Severe Hypoglycemia, Risk of Recurrent Events and Weight Gain on Insulin Therapy in Patients with Type 1 Diabetes Mellitus. [D] . Liu, Zhiwen. 2011

机译：1型糖尿病患者的严重低血糖症，复发事件的风险和胰岛素治疗的体重增加。
6. Achieving the composite end‐point of glycated hemoglobin 7.0 without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis [O] . Xinhua Xiao, Changjiang Wang, Xiaoyang Lai, 2020

机译：在中国2型糖尿病患者中每周一次使用度拉鲁肽实现糖化血红蛋白7.0％的复合终点而无体重增加或低血糖每周一次：事后分析
7. Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies [O] . Jian Kuang, Jiankun Zhu, Siying Liu, 2020

机译：患有2型糖尿病患者曾经每周杜拉蛋白的疗效和安全性：奖项研究后的后HOC分析

Achieving the composite end‐point of glycated hemoglobin <7.0 without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis

著录项

相似文献

相关主题

期刊订阅